Press Releases

Jun 16, 2021

Meridian’s New Master Mix for LAMP Assays Offers a Practical Solution for POC Molecular Detection of RNA viruses

read more

May 27, 2021

Meridian Bioscience to Participate in the 41st Annual William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference

read more

May 17, 2021

Meridian Improves Field-Testing in AgBio with its New Air-Dryable™ qPCR Mix for Crude Plant Samples

read more

May 07, 2021

Meridian Bioscience Reports Strong Growth in Net Revenues and EPS in Second Quarter Fiscal 2021

read more

Apr 28, 2021

Meridian Simplifies Workflows for POC Molecular Tests with a New Lyo-Ready™ LAMP Mix

read more

Apr 19, 2021

Meridian Bioscience to Hold Second Quarter Fiscal 2021 Financial Results Conference Call on May 7, 2021

read more

Apr 01, 2021

Meridian Bioscience Announces FDA Submission for New Curian® Campy Assay

read more

Mar 08, 2021

Meridian Launches its New Air-Dryable Mix for Crude Blood Samples

read more

Mar 04, 2021

Meridian Bioscience to Participate in H.C. Wainwright Global Life Sciences 2021 Virtual Conference

read more

Feb 23, 2021

Meridian Bioscience Corrects Prior Update Regarding Revogene® SARS-CoV-2 EUA Withdrawal

read more

Feb 23, 2021

Meridian Bioscience Provides a Further Update on the Revogene® SARS-CoV-2 EUA Submission

read more

Feb 16, 2021

Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission

read more

Feb 05, 2021

Meridian Bioscience Reports Record Setting First Quarter Fiscal 2021 Operating Results and Raises Full Year Fiscal 2021 Guidance

read more

Feb 03, 2021

Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the Village of Newtown

read more

Feb 02, 2021

Meridian’s Air-Dryable Master Mixes Replace Lyophilization in the Manufacturing of Molecular Assays

read more

Jan 13, 2021

Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021

read more

Jan 07, 2021

Meridian Bioscience Announces Better-than-expected Preliminary First Quarter Fiscal 2021 Revenue Results

read more

Jan 06, 2021

Meridian Bioscience to Participate in H. C. Wainright Bioconnect 2021 Virtual Conference

read more

Dec 16, 2020

Meridian Bioscience receives NIH Award for supporting rapid development of Revogene® molecular test for SARS-CoV-2

read more

Dec 08, 2020

Meridian Bioscience submits application to FDA for Emergency Use Authorization for SARS-CoV-2 molecular assay

read more